This review is based on a data search up to the end of January 2012 on strategies in the treatment of non-muscle-invasive bladder cancer.
One of the authors was chairman of the guidelines writing committee of the European Association of Urology, and these guidelines served as a backbone. They are updated and adapted according to the most recent data. It is astonishing how much important data were published in the last 2 years. Many data have a high level of evidence and allow well-supported recommendations. However, recommendations are not given but the discussion for reflection on it is given in this article.
Written by:
Oosterlinck W, Decaestecker K. Are you the author?
Department of Urology, Ghent University Hospital, De Pintelaan, 185, 9000 Ghent, Belgium.
Reference: Expert Rev Anticancer Ther. 2012 Aug;12(8):1097-106.
doi: 10.1586/era.12.87
PubMed Abstract
PMID: 23030228
UroToday.com Bladder Cancer Section
